Delivery Order SPE2DR25D1100-SPE2DR26FCS0Q
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,059.05 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 2, 2025....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $77,518.39. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be sourced from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on July 25, 2025, with a contract ceiling value of $46,927.70 and a completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $17,364.41 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,977.16 to supply Zepbound 15 mg/0.5 mL pen injections, with an ultimate completion date of December 1, 2025. This competitive award with firm fixed pricing reflects the contractor's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,764.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a contract ceiling value of $7,412.22 and an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the vendor's location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.29 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on September 26, 2025, with completion expected by September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,704.30 on November 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures, with an ultimate completion date of November 19, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS0QDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen Drug Corp's substantial pharmaceutical supply relationship with the federal government. The company maintains a prime IDC valued at $999,999,999.00 with DLA Troop Support Medical through December 2026, which serves as the contractual vehicle enabling this delivery order. AmerisourceBergen's contract portfolio demonstrates its critical role as a major pharmaceutical distributor to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, supplying a comprehensive range of medications spanning multiple therapeutic categories from specialty drugs to generic pharmaceuticals across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/30/25 |